NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myelomaDebora Soncini, Michele Cea, Adithya Chedere et al.|Blood Advances|2024Cited by 5
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLSDebora Soncini, Michele Cea, Pamela Becherini et al.|Blood|2023Cited by 0